Mon, Jul 28, 2014, 5:02 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Muscle Pharm Corp. Message Board

  • frank_aldridge frank_aldridge Nov 14, 2013 5:34 PM Flag

    3Q posted

    Gross sales of $31.08M and net sales of $25.34M
    Gross profit of $7.41M or 29% margin
    SG&A of $12.28M

    Discounts included $1.88M associated with the old Assault, so if it is correct to adjust for this as a one time discount, then gorss margin would be 34%. FitMiss sales of $1M and Arnold off to a good start at $3.7M. Hope those number continue to grow though! I think top line revenue growth was quite strong, but I am dissappointed with margins at 29%. If the above adjustment is realistic, then I would be bullish with 34% margins in their first quarter of controlling distribution. This should only improve and bringing mfg. in house could further improve this. SG&A is certainly high, but $4M of that expense was non-cash. Still in an ok position cash wise (new acquisition dependent).

    Will be interested to hear BioZone/Fuse plans tomorrow.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ctruman@rocketmail.com ctruman Nov 14, 2013 5:40 PM Flag

      "At the end of Q3 2013, the Company had approximately $5.7 million of cash and cash equivalents, approximately $9.6 million of inventory, approximately $34.4 million in current assets, and no long-term debt. Shareholders' equity at September 30, 2013 increased to $22.7 million as compared to ($9.8 million) at December 31, 2012."

 
MSLP
10.91-0.09(-0.82%)Jul 28 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.